Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 8/6/2025

Muscle Relaxant Guidelines

Introduction to Muscle Relaxants

  • The American Geriatrics Society guidelines state that muscle relaxants, including methocarbamol, carisoprodol, chlorzoxazone, metaxalone, and cyclobenzaprine, do not directly relax skeletal muscle and have no evidence of efficacy in chronic pain, with potential for adverse effects, especially in older adults 1
  • The American College of Physicians recommends that NSAIDs or acetaminophen be used as first-line options for acute musculoskeletal pain, preferred over muscle relaxants 2

Recommendations for Acute Musculoskeletal Pain

  • For patients concerned about sedation, metaxalone is recommended as the least sedating option 2
  • The American College of Physicians suggests that muscle relaxants, such as cyclobenzaprine, may be beneficial for patients with sleep disturbance from muscle spasm, due to their sedating effect 2

Dosing and Administration

  • The Praxis Medical Insights guidelines recommend starting with the lowest effective dose and using muscle relaxants for short-term only (≤21 days) 3
  • For elderly patients, the initial dose should be reduced by 50% 3

Contraindications and Precautions

  • Muscle relaxants are not recommended for chronic pain management, according to the American Geriatrics Society guidelines 1
  • All muscle relaxants have central nervous system adverse effects, primarily sedation, as stated by the American College of Physicians 2
  • The Praxis Medical Insights guidelines advise avoiding muscle relaxants in patients with significant liver or kidney disease, and avoiding combination with other CNS depressants, including benzodiazepines and opioids 3
  • Patients with neuromuscular disorders should avoid muscle relaxants or use them with careful monitoring, as recommended by the Anaesthesia guidelines 4
  • For patients with liver or kidney disease, the Anaesthesia guidelines suggest considering benzylisoquinoline muscle relaxants (atracurium/cisatracurium) if muscle relaxation is absolutely necessary 4